Risk-Based Therapy for Localized Osteosarcoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk-Based Therapy for Localized Osteosarcoma

Published:2015-10-26 Issue:3 Volume:63 Page:412-417
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Venkatramani Rajkumar¹,Murray Jeffrey²,Helman Lee³,Meyer William⁴,Hicks M. John⁵,Krance Robert¹,Lau Ching¹,Jo Eunji⁶,Chintagumpala Murali¹

Affiliation:

1. Department of Pediatrics; Baylor College of Medicine, Texas Children's Cancer Center; Texas Children's Hospital; Houston Texas

2. Cook Children's Medical Center; Fort Worth Texas

3. National Institutes of Health Clinical Center; Pediatric Oncology Branch; Bethesda Maryland

4. Department of Pediatrics; University of Oklahoma Health Science Center; Oklahoma City Oklahoma

5. Department of Pathology and Immunology and Department of Pediatrics; Baylor College of Medicine; Houston Texas

6. Biostatistics and Informatics Shared Resource; The Dan L. Duncan Cancer Center; Baylor College of Medicine; Houston Texas

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference27 articles.

1. Osteosarcoma: The addition of muramyl tripeptide to chemotherapy improves overall survival-A report from the Children's Oncology Group;Meyers;J Clin Oncol,2008

2. Survival from high-grade localised extremity osteosarcoma: Combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials;Whelan;Ann Oncol,2012

3. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: A report from the Children's Cancer Group;Provisor;J Clin Oncol,1997

4. EURAMOS-1, an international randomised study for osteosarcoma: Results from pre-randomisation treatment;Whelan;Ann Oncol,2015

5. Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: An Italian sarcoma group trial ISG/OS-1;Ferrari;J Clin Oncol,2012

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ct-based intratumoral and peritumoral radiomics for predicting prognosis in osteosarcoma: A multicenter study;European Journal of Radiology;2024-03

2. What has changed in the last 25 years in osteosarcoma treatment? a single center experience;The Turkish Journal of Pediatrics;2023

3. Favorable outcome of high-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with nonmetastatic osteosarcoma and low-degree necrosis;Frontiers in Oncology;2022-09-13

4. An Audit of Delays in the Management of Non-Metastatic Osteosarcoma at a Tertiary Care Center in South India;Cureus;2022-08-07

5. Osteosarcoma;Pediatric Blood & Cancer;2020-08-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3